Ratnakar Securities Pvt. Ltd.

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma

BSE1521.7017.45 (+1.16 %)

PREV CLOSE ( ) 1504.25

OPEN PRICE ( ) 1507.70

BID PRICE (QTY) 1522.00 (10)

OFFER PRICE (QTY) 1522.95 (37)

VOLUME 17784

TODAY'S LOW / HIGH ( )1507.70 1527.00

52 WK LOW / HIGH ( )922.55 1638.7

Select year

Particulars	Mar2023	Mar2022	Mar2021	Mar2020	Mar2019
Profit Before Tax	94084.30	44813.20	27993.70	50095.90	38102.00
Adjustment	27225.60	19749.50	18098.50	19925.40	19686.60
Changes In working Capital	-56618.20	15590.50	25640.90	8985.50	-26960.00
Cash Flow after changes in Working Capital	64691.70	80153.20	71733.10	79006.80	30828.60
Cash Flow from Operating Activities	49593.30	89845.40	61703.70	65547.70	21964.50
Cash Flow from Investing Activities	-79436.80	-57247.40	5362.20	-25888.40	-6812.50
Cash Flow from Financing Activities	23760.70	-51934.60	-59804.80	-57151.40	-27305.20
Net Cash Inflow / Outflow	-6082.80	-19336.60	7261.10	-17492.10	-12153.20
Opening Cash & Cash Equivalents	45082.50	62730.30	56766.10	70623.00	79064.50
Cash & Cash Equivalent on Amalgamation / Take over / Merger	NA	NA	NA	NA	NA
Cash & Cash Equivalent of Subsidiaries under liquidations	5666.90	414.50	NA	NA	455.20
Translation adjustment on reserves / op cash balalces frgn subsidiaries	NA	NA	NA	NA	NA
Effect of Foreign Exchange Fluctuations	1570.70	1274.30	-1296.90	3635.20	3256.50
Closing Cash & Cash Equivalent	46237.30	45082.50	62730.30	56766.10	70623.00

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Cash Flow

SUN PHARMACEUTICAL INDUSTRIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES